NorthStar Medical Radioisotopes has entered into a sponsorship agreement with an undisclosed major U.S. research institution, which will undertake an investigator-initiated research project titled, “Program to Find a Cure for…
NorthStar Medical Radioisotopes and BWXT Medical Ltd., have signed a master services agreement that will facilitate the production of actinium-225 (Ac-225), a medical isotope used to kill cancer cells while…
NorthStar Medical Radioisotopes has amended and expanded its existing collaboration with Monopar Therapeutics, the company announced recently. According to a release, the long-term, non-exclusive master supply agreement states that NorthStar…
NorthStar Medical Radioisotopes is signing a clinical supply agreement with Clarity Pharmaceuticals for the production of 67Cu-SAR-bisPSMA drug product for Clarity’s Phase I/II and Phase III trials, the company recently…
NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…
NorthStar Medical Radioisotopes has established a partnership with Curadh MTR Inc., a global molecularly targeted radiation (MTR)-focused organization, the company announced recently. According to a release, NorthStar will supply its…
NorthStar Medical Radioisotopes announced today the first patient to be treated using the radioisotope Copper-67 (Cu-67) produced from its electron accelerator. According to a release, the administration of the therapeutic…
NorthStar Medical Radioisotopes announced today that it will provide Bayer with its environmentally preferred, non-carrier added (n.c.a.) therapeutic medical radioisotope, actinium‐225 (Ac‐225). “We are very pleased to enter this Ac-225…
NorthStar Medical Radioisotopes has received a custom-built IBA Rhodotron TT 300-HR electron beam accelerator to its new Ac-225 Production facility, the organization announced recently. According to a release, the accelerator…
NorthStar Medical Radioisotopes is collaborating with Inhibrx, a biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, the company announced recently. According to a release, the…
